 |
|
|
|
|
Minnesota Life Science Industry Directory
Target your advertising by state, region or nationwide for the same low rate
Banner Advertising | Event Advertising
Stereotaxis, Inc.
| | | | | Phone: | (763) 493-6364 | | Fax: | (763) 493-7849 | | Year Established: | 1990 | | Ticker: | STXS | | Exchange: | NASDAQ | | Main Contact: | David Fischel, Acting CEO | | | | Other Contacts: | Martin Stammer, CFO
Gery Tomassoni M.D. FHRS, CMO
Melissa Walker, MS, RAC, Senio VP, Regulatory, Quality, and Compliance
Doug Bruce, CTO
Lou Ruggiero, CCO
| | | | Company Description | | Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure. Stereotaxis' Odyssey(TM) solutions integrate and manage information from disparate information sources, eliminating the challenge of interacting simultaneously with many separate diagnostic systems, driving optimized workflow and improved productivity. The core components of the Stereotaxis system have received regulatory clearance in the U.S., Europe and Canada. | |
|
|
|
|
|
|
|
